New study aims to predict cancer treatment success with scans and DNA

NCT ID NCT07259915

Not yet recruiting Knowledge-focused Sponsor: Centre Henri Becquerel Source: ClinicalTrials.gov ↗

First seen Jan 10, 2026 · Last updated May 14, 2026 · Updated 14 times

Summary

This study looks at whether combining medical scans (CT, MRI, PET) with tumor DNA tests can better predict how head and neck cancer responds to chemoradiotherapy. About 152 adults with certain stages of oropharynx or oral cavity cancer will be followed for 12 months after treatment. The goal is to improve personalized treatment decisions, not to test a new therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre Henri Becquerel

Rouen, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Centre Hospitalier Universitaire

Rouen, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)